Article
Anakinra treatment in patients with familial Mediterranean fever: a single-centre experience.
Rheumatology (Oxford, England) - 14 May 2021
Ugurlu Serdal, Ergezen Bilgesu, Egeli Bugra Han, Selvi Oguzhan, Ozdogan Huri
Abstract excerpt
OBJECTIVES: Anakinra is proven to be effective in controlled trials in terms of attack frequency and subclinical inflammation in colchicine-resistant patients. The objective of this study was to review the patients followed in our single centre with FMF who received anakinra because of insufficient colchicine response. METHODS: The study was conducted at a tertiary rheumatology centre experienced in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
